|
|
Article: Methicillin-resistant Staphylococcus aureus skin infections.(Letter to the Editor)
- Article from:
- Emerging Infectious Diseases
- Article date:
- October 1, 2005
- Author:
CopyrightCOPYRIGHT 2005 U.S. National Center for Infectious Diseases. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
To the Editor: Moran et al. write, "In areas with a high prevalence of CA-MRSA [community acquired methicillin-resistant Staphylococcus aureus], empiric treatment for skin and soft tissue infections (SSTIs) with [beta]-lactam agents such as cephalexin may no longer be appropriate. Oral agents such as clindamycin or trimethoprim/sul famethoxazole and rifampin should be considered in CA-MRSA" (1). However, some studies have had different results. Lee et al. reported that 31 (84%) of 37 Texas children with CA-MRSA SSTIs showed clinical improvement after incision and drainage, even though they received an "ineffective" antimicrobial agent that was not changed after the ...